Maternal mortality among women with sickle-cell disease in France, 1996-2009

详细信息    查看全文

• 作者：N. Lesage^a ; ^{ninonlesage@gmail.com" class="auth_mail" title="E-mail the corresponding author} ; C. Deneux Tharaux^b ; M. Saucedo^b ; A. Habibi^c ; F. Galacteros^c ; R. Girot^d ; M.H. Bouvier Colle^b ; G. Kayem^a ; ^b
• 关键词：Sickle-cell disease ; Maternal mortality ; Confidential enquiry into maternal deaths
• 刊名：European Journal of Obstetrics & Gynecology and Reproductive Biology
• 出版年：2015
• 出版时间：November 2015
• 年：2015
• 卷：194
• 期：Complete
• 页码：183-188
• 全文大小：309 K

文摘

To describe maternal mortality among women with sickle-cell disease in France.

Study design

Data from the national confidential enquiry into maternal deaths and from reference centres for sickle-cell disease were examined to identify women with this disease who died in France during 1996–2009. The maternal mortality ratio among women with sickle-cell disease was estimated and compared with the ratio in the general population. Characteristics of these women and their pregnancies and circumstances of their deaths were examined in detail.

Results

Fifteen maternal deaths occurred among an estimated 3300 live births to women with sickle-cell disease, for a maternal mortality ratio of 454 per 100 000 live births (95% CI [254; 750]), versus 9.4/100 000 in the general population. Ten women were homozygous (SS) for sickle-cell disease, and five were composite heterozygotes. The episode leading to death appeared in the antepartum period for seven women (47%). Two women died of septic shock during pregnancy, one at 6 weeks, the other at 24 weeks. The other 13 women (87%) died postpartum. Thirteen deaths were directly attributable to sickle-cell disease. The other two maternal deaths, both considered direct obstetric causes, were due to amniotic fluid embolism and septic shock after post-amniocentesis chorioamnionitis. The expert committee on maternal mortality judged seven of these 15 deaths (47%) to be avoidable.

Conclusion

Sickle-cell disease is responsible for a major excess risk of maternal death in France, due mainly to direct complications of the disease.